The U.S. Food and Drug Administration provided an update on a three-part study of LASIK (laser-assisted in situ keratomileusis).
In October 2009, the FDA, the National Eye Institute, and the Department of Defense launched the LASIK Quality of Life (QOL) Collaboration Project. This project examines patient-reported outcomes (PROs) following LASIK, a surgical procedure intended to reduce a person’s dependence on glasses or contact lenses. A PRO is a report of a condition experienced by the patient and reported by the patient, not the health care provider. Read the rest of this entry ?



